Transcription factor-ĸB (NF-ĸB) and renal disease

Kidney International

Volumn 59, Issue 2, 2001, Pages 415-424

  Guijarro, Carlos ^a   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cell proliferation; Dimeric transcription factors; Inflammation; Kidney disease; Nuclear factor B; Transactivation of NF B

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID A PROTEIN; ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; ARACHIDONATE 5 LIPOXYGENASE; BETA 2 MICROGLOBULIN; COMPLEMENT; CYCLOOXYGENASE 2; CYCLOSPORIN A; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; GLUCOCORTICOID RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; PRAVASTATIN; PROTEASOME; PROTEIN P105; STEROID; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; GENE EXPRESSION; HUMAN; INFLAMMATION; KIDNEY DISEASE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

EID: 0035137324     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.059002415.x     Document Type: Article

References (108)

1. Inducibility of the immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
2. Function and activation of NF-κB in the immune system
3. The NF-κB and IκB proteins: New discoveries and insights
4. NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses
5. NF-κB and Rel: Participants in a multiform transcriptional regulatory system
6. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
7. Transcription factor NF-κB regulation of renal fibrosis during ureteral obstruction
8. The central role of nuclear factor-κB in mesangial cell activation
9. The NF-κB activation pathway: A paradigm in information transfer from membrane to nucleus
10. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice
11. Autoregulation of IκBα activity
12. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα
13. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
14. The PEST domain of IκBα is necessary and sufficient for in vitro degradation by mu-calpain
15. Activation of NF-κB in vivo is regulated by multiple phosphorylations
16. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
17. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
18. Interleukin 1 induces NF-κB through its type I but not its type II receptor in lymphocytes
19. TRAF6 is a signal transducer for interleukin- 1
20. The mitogen-activated protein kinase p38 is necessary for interleukin 1β-induced monocyte chemoattractant protein 1 expression by human mesangial cells
21. Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells: Role of oxidation
22. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immuno-globulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase
23. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate: Evidence for involvement of reactive oxygen species
24. Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status
25. Activation of transcription factor NF-κB in experimental glomerulonephritis in rats
26. Signal transduction for nuclear factor-κB activation: Proposed location of antioxidant-inhibitable step
27. Transcriptional activation by NF-κB requires multiple coactivators
28. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP- 1
29. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
30. The p50 subunit of NF-κB associates with the NF-IL 6 transcription factor
31. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
32. Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter
33. Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1β gene
34. Transcriptional regulation of the interleukin-6 gene in mesangial cells
35. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression
36. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor
37. Molecular medicine: Transcription factors
38. In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry
39. Atherosclerosis: An inflammatory disease
40. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
41. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris
42. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol Recurrent Events (CARE) Investigators
43. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992
44. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
45. The nuclear factor-κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
46. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion
47. Role of nuclear factor-κB in atherogenesis
48. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
49. Long-term effects of pravastatin on plasma concentration of C-reactive protein
50. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
51. ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
52. An essential role for NF-κB in preventing TNF-α-induced cell death
53. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
54. Suppression of TNF-α-induced apoptosis by NF-κB
55. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase- 8 activation
56. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
57. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor κB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase
58. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
59. Apoptosis in the pathogenesis and treatment of disease
60. Role and regulation of apoptotic cell death in the kidney: Y 2K update
61. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury
62. Central role of the transcription factor nuclear factor-κB in mesangial cell production of chemokines
63. Lovastatin inhibits lipopolysaccharide-induced NF-κB activation in human mesangial cells
64. Nuclear factor-κB mediates induction of vascular cell adhesion molecule- 1 in glomerular mesangial cells
65. Activation of nuclear factor-κB correlates with MCP- 1 expression by human mesangial cells
66. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1β-induced activation of NF-κB in rat mesangial cells
67. Suppression by cyclosporin A of interleukin 1β-induced expression of group II phospholipase A 2 in rat renal mesangial cells
68. Regulation of nuclear factor κB by corticosteroids in rat mesangial cells
69. Interaction of IgA with Fc α receptors of human mesangial cells activates transcription factor nuclear factor-κB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and 1FN-inducible protein 10
70. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein- 1 synthesis
71. Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells
72. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis
73. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring
74. Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells
75. Angiotensin II activates nuclear transcription factor κB through AT(1) and AT(2) in vascular smooth muscle cells: Molecular mechanisms
76. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: Effects of oxidation and modulation by lovastatin
77. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
78. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
79. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells
80. Regulation of mesangial cell proliferation by the mevalonate pathway
81. Lovastatin inhibits proliferation of rat mesangial cells
82. Selective sensitization to tumor necrosis factor-α-induced apoptosis by blockade of NF-κB in primary glomerular mesangial cells
83. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
84. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: Hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-κB and activating protein-1
85. Cysteine S-conjugates activate transcription factor NF-κB in cultured renal epithelial cells
86. Activation of NF-κB in normal rat kidney epithelial (NRK52E) cells is mediated via a redox-insensitive, calcium-dependent pathway
87. Immuno-regulatory potential of urothelium: Characterization of NF-κB signal transduction
88. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation
89. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor κB in proximal tubule cells
90. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF-κB, and C/EBP transcription factors
91. Role of NFκB in the mortality of sepsis
92. N-acetyl cysteine blocks mesangial VCAM-1 and NF-κB expression in vivo
93. Suppression of NF-κB and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: Molecular mechanisms of anti-nephritic action
94. Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis
95. Tissue factor expression in an animal model of hydronephrosis
96. Rapid communication. Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction
97. Role of TNFR 1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy
98. Differential effects of ACE and AT 1 receptor inhibition on chemoattractant and adhesion molecule synthesis
99. Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats
100. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein- 1 mRNA in nephrotic rats
101. Proteasome inhibition: A novel mechanism to combat asthma
102. Calmodulin dependence of NFκB activation
103. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation
104. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitors, but not with the processing of p105/NF-κB 1 in T cells
105. Cyclosporine a inhibits tissue factor expression in monocytes/macrophages
106. Interleukin 1β-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A
107. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I κB synthesis
108. Role of transcriptional activation of 1 κB α in mediation of immunosuppression by glucocorticoids